L. Potter

The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis

F. Kianifard, A. Landsman, A. Tavakkol, 2007, The Journal of dermatological treatment.

Functional status and somatization as predictors of medical offset in anxious and depressed patients.

D. Patrick, W. Schonfeld, C. Henke, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The OnyCOE-t™ questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis

F. Kianifard, A. Tavakkol, S. Mathias, 2006, Health and quality of life outcomes.

Kaiser Permanente's evaluation and management of biotech drugs: assessing, measuring, and affecting use.

M. Millares, L. Potter, A. Barrueta, 2006, Health affairs.

An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.

B. Parasuraman, R. R. Williams, B. Rittenhouse, 2000, The American journal of managed care.

A health-related quality of life measure for use in patients with onychomycosis: a validation study

D. Lubeck, D. Gause, L. Potter, 2004, Quality of Life Research.

Health-Related Quality of Life in Patients with Toenail Onychomycosis: Data from a 9-Month Observational Study

D. Lubeck, L. Prebil, D. Gause, 1999 .

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a Health Maintenance Organization

T. Levin, J. Henning, C. Henke, 2000, American Journal of Gastroenterology.

Cross‐sectional 7‐year follow‐up of anxiety in primary care patients

C. Rowland, S. Colman, M. Brod, 2004, Depression and anxiety.

Health and Quality of Life Outcomes

F. Kianifard, L. Potter, Susan D Mathias, 2006 .